Skip to main content
. Author manuscript; available in PMC: 2017 Aug 10.
Published in final edited form as: Prostate. 2016 Feb 9;76(7):624–636. doi: 10.1002/pros.23155

Figure 3. Host immune cell-derived CRAMP does not exhibit additional effects in protumorigenic event mediated by prostate tumor-derived CRAMP.

Figure 3

(A) Tumor volume in TRAMP-C1 tumor-bearing CRAMP deficient and wild-type (WT) mice. Data is presented as mm3 (mean ± SE, n=3). (B) The number of immature myeloid progenitors and macrophages from tumor microenvironment was compared between CRAMP deficient and WT mice. The data with absolute number are shown as mean ± SE (n=3). *P < 0.01 **P < 0.005 ***P < 0.001